Evidence map›Paper›PMID 31924697›Full record

ArticleJournal of medical genetics2020

De novo variants in

Roya Bina, Dena Matalon, Brieana Fregeau, Jacqueline Joani Tarsitano, Ingvild Aukrust, Gunnar Houge, Renee Bend, Hannah Warren, Roger E Stevenson, Kyra Eva Stuurman and 2 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00305305 (Disorders of Cerebral Development), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00305305 recruitingnot on this map

Disorders of Cerebral Development: A Phenotypic and Genetic Analysis

TypeobservationalSponsorUniversity of California, San FranciscoRan2003 to 2027Enrolled2,000ConditionsBrain Disorders, Aicardi Syndrome
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. International journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Roya BinaNeurology, UCSF, San Francisco, California, USA.ORCID 0000-0002-1951-2052
Dena MatalonPediatrics, Stanford University, Stanford, California, USA.
Brieana FregeauNeurology, UCSF, San Francisco, California, USA.
Jacqueline Joani TarsitanoNeurology, UCSF, San Francisco, California, USA.
Ingvild AukrustDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Gunnar HougeDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Renee BendGreenwood Genetic Center, Greenwood, South Carolina, USA.
Hannah WarrenGreenwood Genetic Center, Greenwood, South Carolina, USA.
Roger E StevensonGreenwood Genetic Center, Greenwood, South Carolina, USA.
Kyra Eva StuurmanClinical Genetics, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-0257-2059
A James BarkovichDepartment of Radiology, UCSF, San Francisco, California, USA.
Elliott H SherrNeurology, UCSF, San Francisco, California, USA Elliott.Sherr@ucsf.edu.
University of California, San Francisco · USGreenwood Genetic Center · USHaukeland University Hospital · NOErasmus MC · NLStanford University · US

Funding

De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
NINDS NIH HHS R01 NS058721
6 · The paper itself

Abstract

introductionWhole-exome sequencing (WES) has identified de novo variants in chromatin remodelling genes in patients with neurodevelopmental disorders (NDD). We report on a novel genetic discovery in chromatin remodelling in patients with NDD who also have corpus callosum (CC) anomalies.

objectiveTo discover novel genes linked to both CC anomalies and NDD.

methodsClinical WES was performed for evaluation of NDD, identifying five patients with de novo variants in

resultsWe identified four patients with de novo missense variants in

conclusionOur findings implicate the gene

Indexed as

Genetic Predisposition to DiseaseAdolescentAgenesis of Corpus CallosumBrainCell Cycle ProteinsChildChild, PreschoolCorpus CallosumExomeExome SequencingFemaleHumansIntellectual DisabilityMaleMutation, MissenseNeurodevelopmental DisordersCell Cycle ProteinsSUPT16H protein, humanTranscription Factorsdevelopmentalgeneticsother neurology

Identifiers

PMID31924697
PMCPMC9491690
OpenAlexW2999723069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.